Article

jdsupra.com on 2024-04-30 20:53

Biosimilar Approval Updates in Europe and China

On April 25, 2024, the Committee for Medicinal Products for Human Use (“CHMP”) adopted a positive opinion, recommending the granting of marketing ...

Related news

International Biosimilar Approval and Launch Updates jdsupra.com
Shanghai , Taiwan , Macau , Hong Kong , China
Adalimumab Biosimilar Update: Shanghai Henlius Biotech’s Approval in China and Celltrion’s Positive Opinion in the EU jdsupra.com
China
STADA and Xbrane Announce Approval of Ranibizumab Biosimilar in Europe jdsupra.com
Asia-Pacific , North Africa , Middle East , Europe
International Biosimilar Approval and Launch Updates - April 2022 jdsupra.com
Canada , Europe
Rituximab Biosimilar Updates from Europe jdsupra.com
California , United States , Switzerland , Europe
Approval of Denosumab biosimilar and launch of teriparatide biosimilar in China and South Korea jdsupra.com
South Korea , China
Alvotech and STADA obtain approval in Europe for ustekinumab biosimilar, UZPRUVO jdsupra.com
Japan , Canada , Norway , Liechtenstein , Iceland
Samsung Bioepis Seeks Regulatory Approval for an Adalimumab Biosimilar in Europe and South Korea jdsupra.com
South Korea , Europe
Biosimilar Market Updates: Canada, US, China jdsupra.com
California , United States , Switzerland , China , Canada
Celltrion’s Herceptin Biosimilar Submitted For Approval in Europe jdsupra.com
South Korea , Europe
Teva Receives Approval for First Ophthalmology Biosimilar in Europe jdsupra.com
Switzerland , United Kingdom , Europe
Biologic and Biosimilar Approval Updates jdsupra.com
Japan
Biosimilar and Biologic Updates in China: Bevacizumab, Etanercept, Tislezumab, Infliximab, Eculizumab, Adalimumab jdsupra.com
California , United States , Switzerland , China
Enbrel Biosimilar in Europe and US jdsupra.com
Europe
Biosimilar Regulatory Submission Updates: Europe, U.S., Japan, Canada jdsupra.com
California , United States , Switzerland , Canada , Japan
Alvotech and STADA Launch HUKYNDRA® (Biosimilar of HUMIRA®) in Europe jdsupra.com
Liechtenstein , Iceland , Norway , Sweden , Finland
International Biosimilar Market Updates jdsupra.com
Saudi Arabia , Canada , Switzerland , Iceland , Norway
Biosimilar Market Updates: Samsung Biologics, Celltrion, and Alvotech jdsupra.com
Yangtze River , China , Incheon , South Korea
Ranibizumab Biosimilar Program Updates jdsupra.com
United States , New Zealand , Israel , Australia , Japan
European Biosimilar Regulatory Updates jdsupra.com